BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7251224)

  • 21. Derepressed alloantigen in transplacentally induced lung tumor coded for by H-2 linked gene.
    Martin WJ; Gipson TG; Martin SE; Rice JM
    Science; 1976 Oct; 194(4264):532-3. PubMed ID: 973137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells.
    Callahan GN
    J Immunol; 1984 May; 132(5):2649-57. PubMed ID: 6201554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interacting genetic factors controlling the antibody response against the H-2.2 specificity.
    Decoville M; Motta R
    Immunogenetics; 1982 Mar; 15(3):279-85. PubMed ID: 6802752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are methylcholanthrene-induced sarcoma-associated, rejection-inducing (TSTA) antigens, modified forms of H-2 or linked determinants?
    Klein G; Klein E
    Int J Cancer; 1975 Jun; 15(6):879-87. PubMed ID: 50291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung tumor-associated derepressed alloantigen coded for by the K region of the H-2 major histocompatibility complex.
    Gipson TG; Imamura M; Conliffe MA; Martin WJ
    J Exp Med; 1978 May; 147(5):1363-73. PubMed ID: 418138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming.
    Bevan MJ
    J Immunol; 1976 Dec; 117(6):2233-8. PubMed ID: 825578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of non-H-2 genes in the control of the in vivo growth of the virus induced lymphoma YC8.
    Colombo MP; Parmiani G
    J Immunogenet; 1981 Oct; 8(5):405-13. PubMed ID: 6795282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts.
    Drizlikh G; Schmidt-Sole J; Yankelevich B
    J Exp Med; 1984 Apr; 159(4):1070-82. PubMed ID: 6142918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenic variants of a murine fibrosarcoma induced by mutagenesis: requirement of viable cells for antigen-specific cross-protection.
    LeGrue SJ; Simcik WJ; Frost P
    Cancer Res; 1987 Aug; 47(16):4413-6. PubMed ID: 3607772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-specific chemoimmunotherapy of murine fibrosarcoma using tumor-specific transplantation antigen, cyclophosphamide, and interleukin-2.
    Naito K; Nomi S; Komichi H; Ueda Y; Yamagishi H; Oka T; Pellis NR; Kahan BD
    Cancer Detect Prev; 1992; 16(5-6):321-7. PubMed ID: 1361881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical characterization of 1-butanol-extracted murine tumor-specific transplantation antigens.
    LeGrue SJ; Pellis NR; Riley LB; Kahan BD
    Cancer Res; 1985 Jul; 45(7):3164-72. PubMed ID: 2408745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H-2K restriction of the T cell-mediated lysis of a chemically-induced BALB/c fibrosarcoma.
    Colombo MP; Rodolfo M; Parmiani G
    J Immunogenet; 1983 Aug; 10(4):337-40. PubMed ID: 6604758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active specific chemoimmunotherapy of lymph-node metastasis from a poorly immunogenic murine fibrosarcoma.
    Naito K; Oka T; Nomi S; Yamagishi H; Kahan BD
    Jpn J Cancer Res; 1989 Nov; 80(11):1119-26. PubMed ID: 2514172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Separation of the tumor-associated transplantation antigen (TATA) from the alien H-2k antigens expressed on a methylcholanthrene-induced tumor.
    Rogers MJ; Law LW; Pierotti MA; Parmiani G
    Int J Cancer; 1980 Jan; 25(1):105-9. PubMed ID: 7399738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unique and common tumor-specific transplantation antigens of chemically induced mouse sarcomas.
    Hellström KE; Hellström I; Brown JP
    Int J Cancer; 1978 Mar; 21(3):317-22. PubMed ID: 75855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical characterization of alien H-2 antigens expressed on a methylcholanthrene-induced tumor.
    Rogers MJ; Appella E; Pierotti MA; Invernizzi G; Parmiani G
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1415-9. PubMed ID: 286324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of tolerance across major barriers using a two-step method with genetic analysis of tolerance induction.
    Mayumi H; Good RA
    Immunobiology; 1989 Mar; 179(1):86-108. PubMed ID: 2659501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic T-lymphocyte tolerance to minor H-43a alloantigen is induced exclusively in the context of the self major histocompatibility complex class I H-2Kb molecules.
    Ishikawa H; Hino T; Kato H; Suzuki H; Saito K
    Cell Immunol; 1987 Dec; 110(2):436-42. PubMed ID: 3500797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of H-2 positive and H-2 negative clones of a mouse tumour, GR9.
    Garrido ML; Pérez M; Delgado C; Rojano J; Algarra I; Garrido A; Garrido F
    J Immunogenet; 1986; 13(2-3):159-67. PubMed ID: 3819450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.